Catalyst Wire Dossier Catalyst Wire Dossier

Busulfex

busulfan
Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for Busulfex, covering 2007-04-19 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant [Phase 1, Phase 2]

See pricing